ARCHIVES

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Patient Advocacy: congress Delivers Symbolism, Not Solution, Visco Says

October 17, 1997

Two New Modalities Promising For Relapsed/Refractory NHL

January 28, 2005

DCT Issues Two Pas for Small/Exploratory Grants For Clinical, Laboratory Studies

March 23, 1994

Researchers Uncover Tumors Sensitive to Chemotherapy

January 25, 2013

LAK/IL-2 Therapy Could Halt Kidney Cancer Deaths: DeVita

March 21, 1986

NCI Makes First NRS Award – 13 Institution Grants; 150 Individuals Pending: Lepovetsky Training Chief

April 4, 1975